How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

10,381 results for

E/M Medical Decision Making

by
...
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

61. Deceased organ and tissue donation after medical assistance in dying and other conscious and competent donors: guidance for policy

. This avoids the potential distress of making a request or obtaining consent for donation only to have to inform the patient that they are medically or logistically ineligible. Conversations about donation The decision to proceed with MAiD or WLSM must be separate from, and must precede, the decision to donate. Treating physicians, MAiD providers and MAiD assessors should be educated on how to respond to inquiries concerning organ donation. This should include how the decision to donate may affect the end (...) providers and policy-makers. This document is intended to inform policies related to offering organ and tissue donation to patients who have made a decision that will lead to imminent death. These are conscious, competent patients who have chosen to withdraw mechanical ventilation, including invasive or noninvasive GUIDELINE | GUIDANCE FOR POLICY CPD Deceased organ and tissue donation after medical assistance in dying and other conscious and competent donors: guidance for policy James Downar MDCM MHSc

2019 CPG Infobase

62. Jennifer McCaughan and Aisling E Courtney: Is balancing risk the most important skill in clinical medicine?

and stressful cases in the past can distort our decision making in the present. This has the potential to result in suboptimal patient management. The ability to objectively balance the many aspects (surgical, anaesthetic, medical, immunological, psychological) of the risk associated with a treatment against that of avoiding the treatment is an essential skill for physicians. The capacity to do this effectively for each individual patient is the cornerstone of personalised medicine and an attribute (...) Jennifer McCaughan and Aisling E Courtney: Is balancing risk the most important skill in clinical medicine? Jennifer McCaughan and Aisling E Courtney: Is balancing risk the most important skill in clinical medicine? - The BMJ ---> Every decision, both in life and in medicine, involves a balance of risk: the decision to go on holiday balances the risk of travelling to and staying in a foreign country against the benefit of a fortnight’s sunshine and relaxation; the decision to treat bacterial

2017 The BMJ Blog

63. Evidence Brief - Barriers and Facilitators to Use of Medications for Opioid Use Disorder

, PsycINFO, EMBASE and Cochrane Central Register of Controlled Trials (CCRT). We used prespecified criteria for study selection, data abstraction, and rating internal validity and strength of the evidence. See our PROSPERO protocol for our full methods. Evidence Brief: Barriers and Facilitators to Use of Medications for OUD Evidence Synthesis Program 2 American Society of Addiction Medicine recommending them as an option for first-line treatment for OUD. Reasons for underutilization of OUD medications (...) from the Veterans Affairs/Department of Defense (DoD), Centers for Disease Control & Prevention (CDC), and the American Society of Addiction Medicine recommending their use, these medications are underutilized within VHA populations and the general community. 4,16,17 Within VHA, the percentage of Veterans with diagnosed OUD on medication was approximately 39% at the end of the second quarter of 2019. 6 While improved compared to treatment rates of approximately 34% in 2016, this rate of OUD

2019 Veterans Affairs Evidence-based Synthesis Program Reports

64. OWise mobile app and website for supporting women with breast cancer - Innovative Medical Technology Overview

, light-touch summary of the evidence surrounding an innovative technology. An IMTO seeks to offer an early indication of the strengths and weaknesses of the technology, with a view to contributing to local decision-making by NHS health professionals, managers and procurement colleagues. IMTOs are not peer reviewed and do not contain recommendations. IMTOs should be considered alongside existing guidance applicable to NHSScotland. All new and innovative technologies need to have been registered (...) OWise mobile app and website for supporting women with breast cancer - Innovative Medical Technology Overview IMTO | 1 IMTO 02-20 January 2020 OWise mobile app and website for supporting women with breast cancer Innovative Medical Technology Overview Key points ? OWise Breast Cancer is an app and website that offer a suite of tailored information and tools to support women with breast cancer. ? Included in the OWise app is information on disease pathology and care pathways, tailored questions

2020 SHTG Advice Statements

65. Management of Cancer Medication-Related Infusion Reactions

practice guideline, informed by best available evidence and expert consensus, was developed to help standardize the prevention and management of IRs across the province. Definitions The term IR is a broad classification; therefore, a standardized definition is needed to facilitate accurate documentation of reactions and provide guidance on treatment and re-challenge decision-making. An infusion reaction (IR) is any adverse sign or symptom that occurs during the infusion of a medication or within (...) Management of Cancer Medication-Related Infusion Reactions Management of Cancer Medication- Related Infusion Reactions Care has been taken in the preparation of the information contained in this report. Nonetheless, any person seeking to apply or consult the report is expected to use independent medical judgment in the context of individual clinical circumstances or seek out the supervision of a qualified clinician. Cancer Care Ontario makes no representation or guarantees of any kind

2019 Cancer Care Ontario

66. Ustekinumab for the treatment of adult patients with moderately to severely active ulcerative colitis (UC) who have had an inadequate response with, lost response to, or were intolerant to either conventional therapy or a biologic, or have medical contrai

and the MAH performed recal- culation and imputation for four out of seven trials to make the endpoints of re-randomised trials comparable to those of treat-through designs. This resulted in heavy imputation of data. NBF population To increase the statistical power in this model, the MAH pooled doses for treatment arms as no dose–response relationship was observed. However, this decision should not be based on the lack of statistical significance in a data-scarce model, but rather on knowledge from (...) Ustekinumab for the treatment of adult patients with moderately to severely active ulcerative colitis (UC) who have had an inadequate response with, lost response to, or were intolerant to either conventional therapy or a biologic, or have medical contrai October 2019 EUnetHTA Joint Action 3 WP4 1 EUnetHTA Joint Action 3 WP4 Version 1.0, 22/10/2019 Relative effectiveness assessment of pharmaceutical technologies USTEKINUMAB FOR THE TREATMENT OF ADULT PATIENTS WITH MODERATELY TO SEVERELY ACTIVE

2020 EUnetHTA

67. Reproductive services for women at high risk for maternal mortality: a report of the workshop of the Society for Maternal-Fetal Medicine, the American College of Obstetricians and Gynecologists, the Fellowship in Family Planning, and the Society of Family

. Heisler M. Harris L.H. Inpatient postpartum long-acting reversible contraception: care that promotes reproductive justice. Obstet Gynecol. 2017; 130 : 783-787 Society for Maternal-Fetal Medicine Executive summary: Reproductive Services for Women at High Risk for Maternal Mortality Workshop, February 11–12, 2019, Las Vegas, Nevada. Am J Obstet Gynecol. 2019; 221 : B2-B5 Dugas M. Shorten A. Dube E. Wassef M. Bujold E. Chaillet N. Decision aid tools to support women's decision making in pregnancy (...) ; 101 : 1859-1864 Kerns J.L. Mengesha B. McNamara B.C. Cassidy A. Pearlson G. Kuppermann M. Effect of counseling quality on anxiety, grief, and coping after second-trimester abortion for pregnancy complications. Contraception. 2018; 97 : 520-523 Dehlendorf C. Diedrich J. Drey E. Postone A. Steinauer J. Preferences for decision-making about contraception and general health care among reproductive age women at an abortion clinic. Patient Educ Couns. 2010; 81 : 343-348 Elwyn G. Frosch D. Thomson R. et

2020 Society of Family Planning

68. Simplified guideline for prescribing medical cannabinoids in primary care

Simplified guideline for prescribing medical cannabinoids in primary care Vol 64: FEBRUARY | FÉVRIER 2018 | Canadian Family Physician | Le Médecin de famille canadien 111 CLINICAL PRACTICE GUIDELINES Abstract Objective To develop a clinical practice guideline for a simplified approach to medical cannabinoid use in primary care; the focus was on primary care application, with a strong emphasis on best available evidence and a promotion of shared, informed decision making. Methods The Evidence (...) , and content is offered to support shared, informed decision making. Conclusion This simplified medical cannabinoid prescribing guideline provides practical recommendations for the use of medical cannabinoids in primary care. All recommendations are intended to assist with, not dictate, decision making in conjunction with patients. Editor’s key points ? This simplified prescribing guideline was developed with a primary care focus. Guideline contributors were selected based on profession, practice setting

2018 CPG Infobase

69. GASTRIC RESERVOIR NECROSIS POST GASTRO-JEJUNAL BYPASS. THE IMPORTANCE OF CLINICAL EVALUATION IN THE DECISION MAKING PROGRESS: CASE REPORT Full Text available with Trip Pro

GASTRIC RESERVOIR NECROSIS POST GASTRO-JEJUNAL BYPASS. THE IMPORTANCE OF CLINICAL EVALUATION IN THE DECISION MAKING PROGRESS: CASE REPORT 27683797 2018 11 13 2317-6326 29Suppl 1 Suppl 1 2016 Arquivos brasileiros de cirurgia digestiva : ABCD = Brazilian archives of digestive surgery Arq Bras Cir Dig GASTRIC RESERVOIR NECROSIS POST GASTRO-JEJUNAL BYPASS. THE IMPORTANCE OF CLINICAL EVALUATION IN THE DECISION MAKING PROGRESS: CASE REPORT. 136-138 S0102-67202016000600136 10.1590/0102 (...) . Martinez Medrano Arturo A Obesidad y Laparoscopia Avanzada (OLA), Hospital Puerta de Hierro Sur, Guadalajara, Jalisco, México. Aceves Velazquez Eduardo Daniel ED Internal Medicine, Hospital San José Tec de Monterrey, Monterrey, Nuevo León, México. Vargas Maldonado Enrique E Obesidad y Laparoscopia Avanzada (OLA), Hospital Puerta de Hierro Sur, Guadalajara, Jalisco, México. Castillo Salas Edgar E Obesidad y Laparoscopia Avanzada (OLA), Hospital Puerta de Hierro Sur, Guadalajara, Jalisco, México. eng por

2016 Arquivos Brasileiros de Cirurgia Digestiva : ABCD

70. Erratum to: What Middle Phalanx Base Fracture Characteristics are Most Reliable and Useful for Surgical Decision-making? Full Text available with Trip Pro

Erratum to: What Middle Phalanx Base Fracture Characteristics are Most Reliable and Useful for Surgical Decision-making? 26842233 2016 06 30 2016 03 23 1528-1132 474 4 2016 Apr Clinical orthopaedics and related research Clin. Orthop. Relat. Res. Erratum to: What Middle Phalanx Base Fracture Characteristics are Most Reliable and Useful for Surgical Decision-making? 1080-1 10.1007/s11999-016-4728-0 Janssen Stein J SJ Hand and Upper Extremity Service, Department of Orthopaedic Surgery, Yawkey (...) Barreto C J R C Nyszkiewicz R R Sodha S S Ruchelsman D D Bonatz E E Walbeehm E T E Schumer E D E Suarez F F DeSilva G G Gaston R G R Hernandez G R G Nancollas M M Hofmeister E E Fanuele J C J Boretto J G J Choueka J J Huang J I J Wolf J M JM Erickson J M J Howlett J J Taras J J Wint J J Kakar S S Chivers K K Prommersberger K J KJ Lee K K Rumball K M K Kraan G A G Weiss L L Lattanza L L de Mendonça L A L Jr Paz L L Catalano L L 3rd Calcagni M M McAuliffe J J Darowish M M Costanzo R M R Wood M M MM

2016 Clinical Orthopaedics and Related Research

71. Epigenetics and Reproductive Medicine Full Text available with Trip Pro

Epigenetics and Reproductive Medicine Epigenetics and Reproductive Medicine - Huntriss - 2018 - BJOG: An International Journal of Obstetrics & Gynaecology - Wiley Online Library By continuing to browse this site, you agree to its use of cookies as described in our . Search within Search term Search term RCOG Scientific Impact Paper Free Access Epigenetics and Reproductive Medicine Scientific Impact Paper No. 57 on behalf of Corresponding Author E-mail address: Correspondence: Royal College (...) : 840 – 52 . 30 Vermeiden, JP , Bernardus, RE . Are imprinting disorders more prevalent after human in vitro fertilization or intracytoplasmic sperm injection? Fertil Steril 2013 ; 99 : 642 – 51 . 31 Denomme, MM , Mann, MR . Genomic imprints as a model for the analysis of epigenetic stability during assisted reproductive technologies . Reproduction 2012 ; 144 : 393 – 409 . 32 Anckaert, E , De Rycke, M , Smitz, J . Culture of oocytes and risk of imprinting defects . Hum Reprod Update 2013 ; 19 : 52

2018 Royal College of Obstetricians and Gynaecologists

72. The Patient Centred Medical Home: barriers and enablers to implementation

teamwork. Staff experience: Without adequate staff/staff support, the model cannot be adequately implemented or sustained. • Inadequate staff • Staff dissatisfied with roles • Staff burnout. • Participatory decision-making • Having adequate staff • Trust-building exercises. Time: Major change initiatives such as PCMH take time. Beyond implementation, many of the facets of PCMH take time (e.g. preventative measures, care coordination). • Inadequate time allocated to transition to a PCMH • Inadequate (...) time allocated to undertake comprehensive assessments and holistic interventions. • Recognition of the time it takes to make changes • Separate visits for preventive care • The use of electronic medical records (provided they have a user-friendly interface). Health information technology: Benefits of health information technology are widely • Time, effort and other resources for implementation. • Available technology is inadequate to support quality initiatives • Training, specifically, • Applied

2018 Sax Institute Evidence Check

73. Implementing Shared Decision Making in Interprofessional Home Care Teams

Legare, Canada Research Chair in Implementation of Shared Decision Making in Primary Care, CHU de Quebec-Universite Laval ClinicalTrials.gov Identifier: Other Study ID Numbers: 2015-2016 01-01-E First Posted: October 30, 2015 Last Update Posted: October 27, 2017 Last Verified: October 2017 (...) Implementing Shared Decision Making in Interprofessional Home Care Teams Implementing Shared Decision Making in Interprofessional Home Care Teams - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Implementing

2015 Clinical Trials

74. Canadian Association of Gastroenterology Clinical Practice Guideline for the Medical Management of Pediatric Luminal Crohn’s Disease

. No consensus E: In patients with mild to moderate CD, the consensus group does not make a recommendation (for or against) regarding the use of antibiotics to maintain clinical remission. No consensus F: In male patients with CD the consensus group does not make a recommendation (for or against) regarding a thiopurine to maintain remission. No consensus G: In patients with mild to moderate CD, the consensus group does not make a recommendation (for or against) regarding methotrexate monotherapy to induce (...) it with a thiopurine to maintain a durable clinical remission. No consensus L: In patients with CD who have achieved a clinical remission with anti-TNF therapy, the consensus group does not make a recommendation (for or against) regarding assessment for mucosal healing within the first year to determine the need to modify therapy. No consensus M: In patients with moderate to severe CD who fail to achieve or maintain clinical remission with an anti-TNF–based therapy, the consensus group does not make

2019 Canadian Association of Gastroenterology

75. Immediate postpartum long-acting reversible contraception for women at high risk for medical complications Full Text available with Trip Pro

Immediate postpartum long-acting reversible contraception for women at high risk for medical complications SocietyforMaternal-FetalMedicine(SMFM) ConsultSeries#48:Immediatepostpartum long-actingreversiblecontraceptionforwomen athighriskformedicalcomplications Society for Maternal-Fetal Medicine (SMFM); Laura K. Vricella, MD; Lori M. Gawron, MD, MPH; Judette M. Louis, MD, MPH The Society of Family Planning (SFP) endorses this document. The American College of Obstetricians and Gynecologists (...) , and appropriatelybillforservices.Expandingtherangeofhealth- careprofessionalswhoaretrainedtocounselwomenandto insertLARCdevicescouldreducetheburdenonphysicians. ProgramstotrainnursesormidwivesinLARCcounselingas wellasplacementmaybeamodelthatcanbeintegratedinto busy outpatient and inpatient settings. The MFM subspe- cialist can serve as consultant for these teams to help with contraceptive decision making for women with complex medical conditions. Having obstetric care provider cham- pionscanleadtoimplementationofsustainableprogramsin

2019 Society for Maternal-Fetal Medicine

76. Appropriate prescribing of psychotropic medication for non-cognitive symptoms in people with dementia

for depression in a person with dementia 68 3.5 Anticonvulsant medication 69 3.5.1 Carbamazepine 69 3.5.2 Gabapentin 69 3.5.3 Sodium valproate 70 3.5.4 Lamotrigine 70 3.5.5 Summary of evidence and recommendations for anticonvulsant medication 70 3.6 Benzodiazepines 71 3.7 Z-drugs (hypnotics) and melatonin 73 3.8 Supporting decision making with regards to psychotropic medication 75 3.8.1 What information must be discussed? 75 3.8.2 Capacity of person to make decisions 75 3.8.3 Making decisions if capacity (...) will and preferences concerning treatment decisions that may arise in respect of him or her if he or she subsequently lacks capacity, and (b) in relation to a designated healthcare representative, means the advanced expression under which the representative was designated as such representative (Assisted Decision-Making (Capacity) Act, 2015). Adverse effects An undesired harmful effect resulting from a medication or other intervention. Aggression Feelings of anger or antipathy resulting in hostile or violent

2019 National Clinical Guidelines (Ireland)

77. Statement on Environmental Sustainability in Anaesthesia and Pain Medicine Practice

will be most affected and are least able to affect change. In Australia, over 7% of national carbon emissions is from the healthcare sector. 2 In the United Kingdom, ~5% of acute hospital carbon release has been estimated to be a direct result of anaesthesia. 3 All healthcare workers, including anaesthetists are in a position to significantly reduce greenhouse gas emission by making clinical and non-clinical decisions with regard to the environment. As described in the background paper PS64BP (...) programs can reduce operating theatre waste to landfill by up to 60%. Manufacturing goods using recycled products uses less fossil fuels. Most waste can be recycled if not contaminated by body fluids. Items which can be recycled include paper/cardboard, blue surgical/equipment wrapping, plastics, glass (including drug vials as drugs remain present in only small amounts and glass-making temperatures are sufficient to render drugs inert), batteries, fluorescent light bulbs and electronics (under e

2019 Australian and New Zealand College of Anaesthetists

78. Medical management of abortion

the option of starting hormonal contraception immediately after the first pill of the medical abortion regimen. Notes: • All individuals who can become pregnant should be provided with all of the necessary information to make an informed decision regarding the use of contraception. Immediate initiation of intramuscular (IM) depot medroxyprogesterone acetate (DMPA) is associated with a slight decrease in the effectiveness of medical abortion regimens (67). However, immediate initiation of DMPA should (...) still be offered as an available contraceptive method after an abortion. • Indirect evidence was used as a basis for decision-making on initiation of hormonal contraception as an option for individuals undergoing medical abortion with misoprostol alone. • No data were available on the use of combined hormonal contraception (pills or injections) by those undergoing medical abortion. RECOMMENDATION TYPE: NEW OR UPDATED Recommendation 4a is a new recommendation. 3.5.2 Timing of post-abortion

2019 World Health Organisation Guidelines

79. Patient-centered Outcomes Research in Pulmonary, Critical Care, and Sleep Medicine: A Workshop Report

communication and shared decision making Truth, relevance, and content validity Patients involved from inception identi?ed research questions, reviewed PROMIS tools, helped monitor recruitment, interpreted results, and identi?ed relevance/ dissemination for different groups Effects on communication and medical decision making Ability to detect change and discrimination “Value” and implication of study results De?nition of abbreviations: PRO=patient-reported outcomes; PROMIS=Patient-Reported Outcomes (...) . Correspondence and requests for reprints should be addressed to Erin K. Kross, M.D., Division of Pulmonary and Critical Care, University of Washington, Harborview Medical Center, 325 9th Avenue, Box 359762, Seattle, WA 98104. E-mail: ekross@uw.edu. This article has an online supplement, which is accessible from this issue’s table of contents at www.atsjournals.org. Ann Am Thorac Soc Vol 15, No 9, pp 1005–1015, Sep 2018 Copyright© 2018 by the American Thoracic Society DOI: 10.1513/AnnalsATS.201806-406WS

2019 American Thoracic Society

80. American Gastroenterological Association Institute Guideline on the Medical Management of Opioid-Induced Constipation Full Text available with Trip Pro

and Hepatology, University of North Carolina School of Medicine, Chapel Hill, North Carolina Correspondence Reprint requests Address requests for reprints to: Seth D. Crockett, MD, MPH, Division of Gastroenterology and Hepatology, University of North Carolina, CB 7080, 130 Mason Farm Road, Chapel Hill, North Carolina 27599. fax: (919) 966-8929. , x Katarina B. Greer Affiliations Division of Gastroenterology and Liver Disease, University Hospitals Cleveland Medical Center, Cleveland, Ohio 2 , x Joel J (...) . Heidelbaugh Affiliations Departments of Family Medicine and Urology, University of Michigan Medical School, Ann Arbor, Michigan 3 , x Yngve Falck-Ytter Affiliations Division of Gastroenterology, Case Western Reserve University and Louis Stokes Veterans Affairs Medical Center, Cleveland, Ohio 4 , x Brian J. Hanson Affiliations Division of Gastroenterology, University of Minnesota and Minneapolis Veterans Affairs Health Care System, Minneapolis, Minnesota 5 , x Shahnaz Sultan Affiliations Division

2019 American Gastroenterological Association Institute

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>